Similarly, the RKTG/PAQR3-mediated inactivation of the PI3K/AKT signaling pathway leads to the inhibition of in vitro glioma cell proliferation and attenuates in vivo xenograft tumor growth [69]. This evidence concerns the gene AKT1 and central nervous system cancer.